Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruizhe Zhao

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Plos One|June 13, 2015
Genetic Variants in Caveolin-1 and RhoA/ROCK1 Are Associated with Clear Cell Renal Cell Carcinoma Risk in a Chinese PopulationRuizhe Zhao, Kang Liu, Zhengkai Huang, et al.
International Journal of Clinical and Experimental Medicine|February 10, 2015
Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tractXiaheng Deng, Xiao Yang, Yidong Cheng, et al.
Plos One|May 8, 2014
Meta-analysis reveals a lack of association between UGT2B17 deletion polymorphism and tumor susceptibilityXiaheng Deng, Yidong Cheng, Xiao Yang, et al.
Cell Death & Disease|December 20, 2025
Tubule-derived CCN1 drives renal repair via α<sub>v</sub>β<sub>5</sub>-STAT6-ARG1-dependent reprogramming of macrophagesNingxin Zhang, Chenyu Li, Yanlu Xin, et al.
Current Treatment Options in Oncology|January 30, 2025
Advancements in Diagnosis and Treatment of Cardiac Sarcomas: A Comprehensive ReviewXuezhe Wang, Xinchi Luan, Wenwen Yin, et al.
Optics Express|October 29, 2020
Giant polarization anisotropic optical response from anodic aluminum oxide templates embedded with plasmonic metamaterialsYuyi Feng, Paul Leiderer, Ruizhe Zhao, et al.
Bioactive Materials|February 3, 2025
Progress in enzyme-powered micro/nanomotors in diagnostics and therapeuticsJinpeng Zhao, Banghui Wang, Mingzhe Yan, et al.
Cancer Letters|September 1, 2024
Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapyQinju He, Yuanzhen Zhang, Wenchao Li, et al.
DNA and Cell Biology|March 27, 2015
miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cellsYiyang Liu, Mingcong Zhang, Jian Qian, et al.
Nature Communications|September 8, 2018
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responsesQiuhui Li, Qu Deng, Hsueh-Ping Chao, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Plos One|June 13, 2015
Genetic Variants in Caveolin-1 and RhoA/ROCK1 Are Associated with Clear Cell Renal Cell Carcinoma Risk in a Chinese PopulationRuizhe Zhao, Kang Liu, Zhengkai Huang, et al.
International Journal of Clinical and Experimental Medicine|February 10, 2015
Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tractXiaheng Deng, Xiao Yang, Yidong Cheng, et al.
Plos One|May 8, 2014
Meta-analysis reveals a lack of association between UGT2B17 deletion polymorphism and tumor susceptibilityXiaheng Deng, Yidong Cheng, Xiao Yang, et al.
Cell Death & Disease|December 20, 2025
Tubule-derived CCN1 drives renal repair via α<sub>v</sub>β<sub>5</sub>-STAT6-ARG1-dependent reprogramming of macrophagesNingxin Zhang, Chenyu Li, Yanlu Xin, et al.
Current Treatment Options in Oncology|January 30, 2025
Advancements in Diagnosis and Treatment of Cardiac Sarcomas: A Comprehensive ReviewXuezhe Wang, Xinchi Luan, Wenwen Yin, et al.
Optics Express|October 29, 2020
Giant polarization anisotropic optical response from anodic aluminum oxide templates embedded with plasmonic metamaterialsYuyi Feng, Paul Leiderer, Ruizhe Zhao, et al.
Bioactive Materials|February 3, 2025
Progress in enzyme-powered micro/nanomotors in diagnostics and therapeuticsJinpeng Zhao, Banghui Wang, Mingzhe Yan, et al.
Cancer Letters|September 1, 2024
Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapyQinju He, Yuanzhen Zhang, Wenchao Li, et al.
DNA and Cell Biology|March 27, 2015
miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cellsYiyang Liu, Mingcong Zhang, Jian Qian, et al.
Nature Communications|September 8, 2018
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responsesQiuhui Li, Qu Deng, Hsueh-Ping Chao, et al.
Pageof 5